Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis

Clinical trial NCT05363891 · COMPLETED

Trial details

NCT number: NCT05363891
Sponsor: XBiotech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2023-08-08
Primary completion: 2024-10-31
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.